Close Menu

coronary artery disease

An international research consortium finds a genetic link between height and risk of coronary artery disease.

The data, presented at the American College of Cardiology meeting, showed that doctors referred only 4 percent of women with low Corus CAD scores for further cardiac evaluation.

A meta-analysis on tens of thousands of individuals suggests cholesterol-lowering statin drugs may be particularly beneficial for those genetically prone to heart disease.

In an SEC document, the company called current market conditions for an IPO unattractive. 

CardioDx Raises $35M

The financing will go toward further commercialization of its Corus CAD test, as well as other genomics tests for coronary artery disease. 

NEW YORK (GenomeWeb) – Results of a single-center retrospective study focusing on a predominately African-American patient population have added to mounting evidence that Corus CAD, CardioDx's gene expression-based coronary artery disease rule-out test, can help clinicians avoid unnecessary refer

NEW YORK (GenomeWeb) – Cardiovascular molecular diagnostics company CardioDx has raised $21 million toward a targeted goal of $25 million, it disclosed in a regulatory document filed on Wednesday.

NEW YORK (GenomeWeb) – CardioDx today announced that Aetna has established a clinical policy for the Corus CAD gene expression test for coronary artery disease.

NEW YORK (GenomeWeb) – CardioDx's 2013 revenues increased more than three-fold year over year, the company said in a regulatory document on Monday.

NEW YORK (GenomeWeb News) – Medison will make available CardioDx's Corus CAD diagnostic test for obstructive coronary artery disease in Israel as part of an agreement announced today.

Pages

Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.

In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.